articleNew England Journal of MedicineJun 20, 2007BRONZE OA

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Mayo Clinic · Cancer Research And Biostatistics

PubMed
Indexed incrossrefpubmed

Abstract

Background

Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Prognostic factors for the progression and outcome of this disease are unclear.

Methods

We searched a computerized database and reviewed the medical records of all patients at Mayo Clinic who fulfilled the criteria of the International Myeloma Working Group for the diagnosis of smoldering multiple myeloma between 1970 and 1995. Bone marrow aspirate and biopsy specimens were studied, and patients were followed throughout the course of disease.

Citation impact

917
total citations
FWCI
15.76
Percentile
100%
References
27
Citations per year

Authors

12

Topics & keywords

Keywords
  • Multiple myeloma
  • Medicine
  • Asymptomatic
  • Bone marrow
  • Myeloma protein
  • Monoclonal gammopathy of undetermined significance
  • Internal medicine
  • Amyloidosis
No related works found for this paper.